Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
Clinical and Experimental Gastroenterology · 2021-08 · Volume 14 · 343-351
DOI: 10.2147/ceg.s237653 ↗At a glance
Übersichtsarbeit in Clinical and Experimental Gastroenterology, 2021-08. Written by Kartikeya Tripathi and 3 co-authors. Institution: Department of Gastroenterology, University of Massachusetts Medical School - Baystate Campus, Springfield, MA, USA. Cited 25 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY-NC 3.0).
Abstract (original language)
Abstract non disponibile.
Subjects
Author keywords
Authors and institutions
- Department of Gastroenterology, University of Massachusetts Medical School - Baystate Campus, Springfield, MA, USA.
- Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
ORCID profiles: Jeffrey Dong
Cite
APA
Tripathi, K., Dong, J., Mishkin, B. F., & Feuerstein, J. D. (2021). Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis. Clinical and Experimental Gastroenterology, Volume 14, 343-351. https://doi.org/10.2147/ceg.s237653
Vancouver
Tripathi K, Dong J, Mishkin BF, Feuerstein JD. Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis. Clinical and Experimental Gastroenterology. 2021;Volume 14:343-351. doi:10.2147/ceg.s237653
BibTeX
@article{Tripathi2021,
author = {Tripathi, Kartikeya and Dong, Jeffrey and Mishkin, Brooke F and Feuerstein, Joseph D},
title = {Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis},
journal = {Clinical and Experimental Gastroenterology},
year = {2021},
volume = {Volume 14},
pages = {343--351},
doi = {10.2147/ceg.s237653}
}
EUVIMED